Related Experiment Video
Updated: Apr 22, 2026

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
25.1K
StimVision: smartphone video kinematics to optimize DBS programming in Parkinson's disease
Florian Lange1, Philipp Köberle2, Gamze Adaçay2
1Department of Neurology, University of Würzburg, Würzburg, Germany. Lange_L@ukw.de.
NPJ Parkinson'S Disease
|April 20, 2026
Summary
Smartphone video analysis offers an objective method for optimizing deep brain stimulation (DBS) in Parkinson's disease. This framework, StimVision, quantifies motor improvements, aiding in personalized treatment and comparing therapies.
Area of Science:
- Neurology
- Biomedical Engineering
- Movement Disorders
Background:
- Deep brain stimulation (DBS) is crucial for Parkinson's disease (PD) motor management.
- Current DBS programming is subjective and time-consuming.
- Objective tools are needed for precise DBS optimization and therapy comparison.
Purpose of the Study:
- To evaluate a smartphone video-based kinematic framework (StimVision) for objective DBS programming.
- To characterize motor signatures associated with effective DBS settings.
- To enable within-session optimization of DBS parameters.
Main Methods:
- Fifteen Parkinson's disease patients with subthalamic DBS underwent testing in a medication-off state.
- Markerless pose estimation from 60 fps smartphone video captured kinematic data.
- A Dynamically Weighted Improvement Score (DWIS) objectively ranked stimulation programs.
Main Results:
- StimVision identified a unique, stable optimal DBS program for each patient.
- Optimal settings significantly improved movement speed, rhythm, and consistency.
- Kinematic domains included Movement Speed, Movement Consistency, and Rhythm & Timing.
Conclusions:
- Smartphone kinematics provide objective, quantitative data for DBS optimization in Parkinson's disease.
- StimVision enables personalized DBS programming and facilitates comparison with pharmacological treatments.
- This approach offers a standardized framework for evaluating motor therapies.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson Disease l: Introduction
6
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
6
Parkinson's Disease: Overview
2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
Parkinson Disease ll: Pathophysiology
11
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
11

